Treatment adherence and psychosocial impact of tinea capitis in families: Qualitative pilot study

Andersen, Pernille Lindsø; Jemec, Gregor B. E.; Saunte, Ditte Marie Lindhardt

doi:10.1111/dth.13570

Cited by 11 publications

(12 citation statements)

References 27 publications

(58 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…10,11 For tinea capitis (n = 2), one study explored insurance and medication coverage as a barrier, while another explored the sociocultural and individual factors such as medical knowledge and language. 12,13 Among the studies without a pathological context (n = 4), two studies examined wait times, one examined language barriers, and the final article explored Medicaid and geography. [14][15][16][17] F I G U R E 1 Search flow for literature exploring barriers to healthcare access in pediatric dermatology | 15 Pediatric Dermatology TOY BS eT al.…”

Section: Specific Dermatological Conditionsmentioning

confidence: 99%

See 1 more Smart Citation

Barriers to healthcare access in pediatric dermatology: A systematic review

Toy

Gregory

Rehmus

2021

Pediatric Dermatology

View full text Add to dashboard Cite

Barriers to healthcare access (BtHA) are factors that prevent a patient or patient population from obtaining necessary medical care. 1 Past research has revealed that BtHA are multifactorial, and in some instances, may manifest from or propagate an existing health inequity. BtHA can be categorized as systemic, sociocultural, or individual barriers. 1,2 Systemic barriers include those that arise from legal frameworks, governmental policies or institutional policies and practices. 2 For example, requiring a fixed address for identification and health insurance can act as a systemic barrier against homeless patients. Meanwhile, sociocultural barriers include factors arising from a group characteristic, such as a race/ethnicity, religion, or locality. 2 Common barriers that fall within this category stem from communication difficulties or a lack of comfort in seeking care. Individual barriers refer to characteristics unique to a patient that negatively impacts their access to health care. 1,2 These can include being overburdened with responsibilities, having previously experienced discrimination in health care or having medical and/or mental health conditions that make healthcare access challenging.Within the last two decades, a growing number of studies have examined BtHA in the context of medical specialties. These studies have confirmed that BtHA such as geography, wait times, insurance, healthcare knowledge, language, and race/ethnicity apply beyond primary care specialties. Dermatology is not immune to these issues with some studies identifying unique health inequities and barriers.For example, some studies have found an underrepresentation in the number of healthcare providers of ethnic minorities and limited institutional training and exposure to skin of color. 3,4 Improvement to either domain may lead to increased patient satisfaction and outcomes for African American patients. 4,5 In contrast to adult dermatology, little research has been conducted on BtHA within the context of pediatric dermatology. Pediatric patients likely have additional unique barriers due to factors such as their reliance on caregivers and the local availability of pediatric dermatologists. This systematic review

show abstract

Section: Specific Dermatological Conditionsmentioning

confidence: 99%

“…Language barriers were found to directly lead to misunderstandings during consultations and improper use of medication. 13…”

Section: Sociocultural Barriersmentioning

confidence: 99%

Barriers to healthcare access in pediatric dermatology: A systematic review

Toy

Gregory

Rehmus

2021

Pediatric Dermatology

View full text Add to dashboard Cite

show abstract

“…Figure 1 shows the PRISMA flow diagram of the selection criteria. A total of 1398 studies were screened, and 249 studies (17.8%) were ultimately included in the database …”

Section: Resultsmentioning

confidence: 99%

Publication Trends of Qualitative Research in Dermatology

2023

View full text Add to dashboard Cite

ImportanceQualitative studies serve as a tool for dermatologists and researchers in dermatology to engage with and understand perspectives of populations with different cultures and backgrounds.ObjectiveTo assess (1) current approaches to qualitative dermatologic research and (2) the publication trends of these studies with the aim to inform researchers regarding qualitative research and its significance and applicability in the field of dermatology.Evidence ReviewA scoping review was conducted in which PubMed and CINAHL Plus were searched using dermatology AND qualitative, dermatology, and 7 qualitative methods terms. Studies were selected for inclusion using 3 levels of screening. Level 1 excluded articles published in a language other than English. Level 2 excluded articles of studies involving mixed methods, quantitative methods, systematic review, and meta-analysis. Level 3 excluded articles that were not specific to general dermatology, medical dermatology, pediatric dermatology, dermatologic surgery, dermatopathology, or education and training associated with dermatology. Finally, all duplicates were removed. The searches were conducted from July 23 to 28, 2022. All articles obtained from PubMed and CINAHL Plus searches were recorded in REDCap.FindingsA total of 1398 articles were reviewed, and of these, 249 (17.8%) were qualitative dermatology studies. Common qualitative methods included content analysis (58 [23.3%]) and grounded theory/constant comparison (35 [14.1%]). Individual interviews were the most common data collection method (198 [79.5%]), and patients (174 [69.9%]) were the most common participant type. Patient experience (137 [55.0%]) was the most common investigated topic. Overall, 131 qualitative studies (52.6%) in dermatology were published in dermatology journals, and 120 qualitative studies (48.2%) in dermatology were published between 2020 and 2022.Conclusions and RelevanceQualitative research in dermatology is becoming more prevalent. There is value in qualitative research, and we encourage researchers in dermatology to incorporate qualitative methods in their studies.

show abstract

“…AC treatment with ketoconazole, povidone‐iodine, miconazole and an unspecified antifungal agent was found to be safe, and furthermore, all showed a significant efficacy in mycological eradication. The disadvantages of topical administration of antifungals are few apart from the convenience of application of the formulations, a lack of motivation when treating an invisible condition, cumbersome in use as it takes 5 min on scalp before rinsing and the economic burden related to treatment cost 39 …”

Section: Discussionmentioning

confidence: 99%

Tinea capitis asymptomatic carriers: what is the evidence behind treatment?

Aharaz

Jemec

Hay

et al. 2021

Acad Dermatol Venereol

Self Cite

View full text Add to dashboard Cite

Tinea capitis is a fungal infection mostly affecting children. Epidemiology is changing over time due to migration, and it has been estimated that up to 40% of children from certain developing countries are affected. The mechanism of transmission is still unclear although asymptomatic carriage seems to have an influence in establishing persistent reservoirs that can cause or fuel epidemics. Screening and prophylactic treatment of close contacts of tinea capitis patients are therefore recommended by several international guidelines, but vaguely and not consistent. The treatments involved can be expensive, hard to integrate in everyday life, have well-known side effects and some are not approved for the treatment of children. The aim of this review was to clarify the evidence behind treatment of human asymptomatic carriers of tinea capitis. Databases were searched for the 'tinea capitis', 'carriers' and 'treatment'. Inclusion criteria were clinical trials, observational and interventional studies including case series (10+ cases) and case reports in English, Danish, Swedish, Norwegian and French. Reviews, guidelines, unclear reports and in vitro trials were excluded. A systematic review identified 10 studies with low to moderate evidence levels. The topical treatments ketoconazole, povidone-iodine, miconazole and the systemic antifungals terbinafine and itraconazole have all shown significant effects in the mycological eradication of fungal conidia. General prophylactic hygienic measures may have a benefit. The scientific evidence behind the treatment of asymptomatic carriage of scalp dermatophytes is sparse and not of high quality. Yet, both topical and systemic antifungal agents show treatment efficacy. Considering the possible adverse effects, topical agents are preferable, but with necessary attention to the compliance of asymptomatic contacts with treatment.

show abstract

Treatment adherence and psychosocial impact of tinea capitis in families: Qualitative pilot study

Cited by 11 publications

References 27 publications

Barriers to healthcare access in pediatric dermatology: A systematic review

Barriers to healthcare access in pediatric dermatology: A systematic review

Publication Trends of Qualitative Research in Dermatology

Tinea capitis asymptomatic carriers: what is the evidence behind treatment?

Contact Info

Product

Resources

About